Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study

Introduction. Various pain management strategies for patients undergoing open excisional hemorrhoidectomy have been proposed, yet postoperative pain remains a frequent complaint. Objective. To determine whether mesoglycan (30 mg two vials i.m. once/day for the first 5 days postoperative, followed by...

Full description

Bibliographic Details
Main Authors: Gaetano Gallo, Massimiliano Mistrangelo, Roberto Passera, Valentina Testa, Mauro Pozzo, Roberto Perinotti, Ivan Lanati, Ivano Lazzari, Paolo Tonello, Elettra Ugliono, Emilia De Luca, Alberto Realis Luc, Giuseppe Clerico, Mario Trompetto
Format: Article
Language:English
Published: Hindawi Limited 2018-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2018/6423895
id doaj-77732bb08f194734b0b8c5706dd9a41a
record_format Article
spelling doaj-77732bb08f194734b0b8c5706dd9a41a2020-11-24T22:37:41ZengHindawi LimitedGastroenterology Research and Practice1687-61211687-630X2018-01-01201810.1155/2018/64238956423895Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter StudyGaetano Gallo0Massimiliano Mistrangelo1Roberto Passera2Valentina Testa3Mauro Pozzo4Roberto Perinotti5Ivan Lanati6Ivano Lazzari7Paolo Tonello8Elettra Ugliono9Emilia De Luca10Alberto Realis Luc11Giuseppe Clerico12Mario Trompetto13Department of Colorectal Surgery, Santa Rita Clinic, Vercelli, ItalyDepartment of Surgical Science, Città della Salute e della Scienza Hospital, University of Turin, Turin, ItalyNuclear Medicine Department, Città della Salute e della Scienza Hospital, University of Turin, Turin, ItalyDepartment of Surgical Science, Città della Salute e della Scienza Hospital, University of Turin, Turin, ItalyColorectal Surgical Unit, Department of Surgery, Infermi Hospital, Biella, ItalyColorectal Surgical Unit, Department of Surgery, Infermi Hospital, Biella, ItalyDepartment of Surgery, Savigliano Hospital, Savigliano, ItalyDepartment of Surgery, Savigliano Hospital, Savigliano, ItalyDepartment of Surgery, Koelliker Hospital, Turin, ItalyDepartment of Surgical Science, Città della Salute e della Scienza Hospital, University of Turin, Turin, ItalyDepartment of Surgical and Medical Sciences, University “Magna Graecia” of Catanzaro, Catanzaro, ItalyDepartment of Colorectal Surgery, Santa Rita Clinic, Vercelli, ItalyDepartment of Colorectal Surgery, Santa Rita Clinic, Vercelli, ItalyDepartment of Colorectal Surgery, Santa Rita Clinic, Vercelli, ItalyIntroduction. Various pain management strategies for patients undergoing open excisional hemorrhoidectomy have been proposed, yet postoperative pain remains a frequent complaint. Objective. To determine whether mesoglycan (30 mg two vials i.m. once/day for the first 5 days postoperative, followed by 50 mg 1 oral tablet twice/day for 30 days) would reduce the edema of the mucocutaneous bridges and thus improve postoperative pain symptoms. Patients and Methods. For this prospective observational multicenter study, 101 patients undergoing excisional diathermy hemorrhoidectomy for III-IV degree hemorrhoidal disease were enrolled at 5 colorectal referral centers. Patients were assigned to receive either mesoglycan (study group SG) or a recommended oral dose of ketorolac tromethamine of 10 mg every 4–6 hours, not exceeding 40 mg per day and not exceeding 5 postoperative days according to the indications for short-term management of moderate/severe acute postoperative pain, plus stool softeners (control group CG). Results. Postoperative thrombosis (SG 1/48 versus CG 5/45) (p<0.001) and pain after rectal examination (p<0.001) were significantly reduced at 7–10 days after surgery in the mesoglycan-treated group, permitting a faster return to work (p<0.001); however, in the same group, the incidence of postoperative bleeding, considered relevant when needing a readmission or an unexpected outpatient visit, was higher, possibly owing to the drug’s antithrombotic properties. Conclusions. The administration of mesoglycan after an open diathermy excisional hemorrhoidectomy can reduce postoperative thrombosis and pain at 7–10 days after surgery, permitting a faster return to normal activities.http://dx.doi.org/10.1155/2018/6423895
collection DOAJ
language English
format Article
sources DOAJ
author Gaetano Gallo
Massimiliano Mistrangelo
Roberto Passera
Valentina Testa
Mauro Pozzo
Roberto Perinotti
Ivan Lanati
Ivano Lazzari
Paolo Tonello
Elettra Ugliono
Emilia De Luca
Alberto Realis Luc
Giuseppe Clerico
Mario Trompetto
spellingShingle Gaetano Gallo
Massimiliano Mistrangelo
Roberto Passera
Valentina Testa
Mauro Pozzo
Roberto Perinotti
Ivan Lanati
Ivano Lazzari
Paolo Tonello
Elettra Ugliono
Emilia De Luca
Alberto Realis Luc
Giuseppe Clerico
Mario Trompetto
Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study
Gastroenterology Research and Practice
author_facet Gaetano Gallo
Massimiliano Mistrangelo
Roberto Passera
Valentina Testa
Mauro Pozzo
Roberto Perinotti
Ivan Lanati
Ivano Lazzari
Paolo Tonello
Elettra Ugliono
Emilia De Luca
Alberto Realis Luc
Giuseppe Clerico
Mario Trompetto
author_sort Gaetano Gallo
title Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study
title_short Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study
title_full Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study
title_fullStr Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study
title_full_unstemmed Efficacy of Mesoglycan in Pain Control after Excisional Hemorrhoidectomy: A Pilot Comparative Prospective Multicenter Study
title_sort efficacy of mesoglycan in pain control after excisional hemorrhoidectomy: a pilot comparative prospective multicenter study
publisher Hindawi Limited
series Gastroenterology Research and Practice
issn 1687-6121
1687-630X
publishDate 2018-01-01
description Introduction. Various pain management strategies for patients undergoing open excisional hemorrhoidectomy have been proposed, yet postoperative pain remains a frequent complaint. Objective. To determine whether mesoglycan (30 mg two vials i.m. once/day for the first 5 days postoperative, followed by 50 mg 1 oral tablet twice/day for 30 days) would reduce the edema of the mucocutaneous bridges and thus improve postoperative pain symptoms. Patients and Methods. For this prospective observational multicenter study, 101 patients undergoing excisional diathermy hemorrhoidectomy for III-IV degree hemorrhoidal disease were enrolled at 5 colorectal referral centers. Patients were assigned to receive either mesoglycan (study group SG) or a recommended oral dose of ketorolac tromethamine of 10 mg every 4–6 hours, not exceeding 40 mg per day and not exceeding 5 postoperative days according to the indications for short-term management of moderate/severe acute postoperative pain, plus stool softeners (control group CG). Results. Postoperative thrombosis (SG 1/48 versus CG 5/45) (p<0.001) and pain after rectal examination (p<0.001) were significantly reduced at 7–10 days after surgery in the mesoglycan-treated group, permitting a faster return to work (p<0.001); however, in the same group, the incidence of postoperative bleeding, considered relevant when needing a readmission or an unexpected outpatient visit, was higher, possibly owing to the drug’s antithrombotic properties. Conclusions. The administration of mesoglycan after an open diathermy excisional hemorrhoidectomy can reduce postoperative thrombosis and pain at 7–10 days after surgery, permitting a faster return to normal activities.
url http://dx.doi.org/10.1155/2018/6423895
work_keys_str_mv AT gaetanogallo efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT massimilianomistrangelo efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT robertopassera efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT valentinatesta efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT mauropozzo efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT robertoperinotti efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT ivanlanati efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT ivanolazzari efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT paolotonello efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT elettraugliono efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT emiliadeluca efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT albertorealisluc efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT giuseppeclerico efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
AT mariotrompetto efficacyofmesoglycaninpaincontrolafterexcisionalhemorrhoidectomyapilotcomparativeprospectivemulticenterstudy
_version_ 1725715994237730816